Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04315233
Title Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics (CHARGE)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Utah
Indications

triple-receptor negative breast cancer

ovarian serous carcinoma

Therapies

Belinostat + Ribociclib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.